Use of cefotaxime, a β-lactamase stable cephalosporin, in the therapy of serious infections, including those due to multiresistant organisms
- 1 September 1981
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 71 (3) , 435-442
- https://doi.org/10.1016/0002-9343(81)90173-x
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Pharmacokinetics of Intravenous Cefotaxime in Patients Undergoing Chronic HemodialysisTherapeutic Drug Monitoring, 1981
- Cefotaxime kinetics after intravenous and intramuscular injection of single and multiple dosesClinical Pharmacology & Therapeutics, 1980
- Activity of the cefotaxime (HR756) desacetyl metabolite compared with those of cefotaxime and other cephalosporinsAntimicrobial Agents and Chemotherapy, 1980
- INTRAVENOUS CEFOTAXIME IN CHILDREN WITH BACTERIAL MENINGITISThe Lancet, 1980
- Pharmacokinetics of cefotaximeAntimicrobial Agents and Chemotherapy, 1979
- HR 756, a New Cephalosporin Active Against Gram-Positive and Gram-Negative Aerobic and Anaerobic BacteriaAntimicrobial Agents and Chemotherapy, 1979
- Cephalothin and Cephaloridine Therapy for Bacterial MeningitisAnnals of Internal Medicine, 1975